Bronchoalveolar Lavage Enzyme-linked Immunospot for a Rapid Diagnosis of Tuberculosis: A Tuberculosis Network European Trialsgroup Study
- 1 October 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 180 (7) , 666-673
Abstract
Rationale: The rapid diagnosis of pulmonary tuberculosis (TB) is difficult when acid fast bacilli (AFB) cannot be detected in sputum smears. Objectives: Following a proof of principle study, we examined in routine clinical practice whether individuals with sputum AFB smear-negative TB can be discriminated from those with latent TB infection by local immunodiagnosis with a Mycobacterium tuberculosis–specific enzyme-linked immunospot (ELISpot) assay. Methods: Subjects suspected of having active TB who were unable to produce sputum or with AFB-negative sputum smears were prospectively enrolled at Tuberculosis Network European Trialsgroup centers in Europe. ELISpot with early-secretory-antigenic-target–6 and culture-filtrate-protein–10 peptides was performed on peripheral blood mononuclear cells (PBMCs) and bronchoalveolar lavage mononuclear cells (BALMCs). M. tuberculosis–specific nucleic acid amplification (NAAT) was performed on bronchoalveolar lavage fluid. Measurements and Main Results: Seventy-one of 347 (20.4%) patients had active TB. Out of 276 patients who had an alternative diagnosis, 127 (46.0%) were considered to be latently infected with M. tuberculosis by a positive PBMC ELISpot result. The sensitivity and specificity of BALMC ELISpot for the diagnosis of active pulmonary TB were 91 and 80%, respectively. The BALMC ELISpot (diagnostic odds ratio [OR], 40.4) was superior to PBMC ELISpot (OR, 10.0), tuberculin skin test (OR, 7.8), and M. tuberculosis specific NAAT (OR, 12.4) to diagnose sputum AFB smear-negative TB. In contrast to PBMC ELISpot and tuberculin skin test, the BALMC ELISpot was not influenced by previous history of TB. Conclusions: Bronchoalveolar lavage ELISpot is an important advancement to rapidly distinguish sputum AFB smear-negative TB from latent TB infection in routine clinical practice.Keywords
This publication has 31 references indexed in Scilit:
- T-cell responses to the Mycobacterium tuberculosis-specific antigens in active tuberculosis patients at the beginning, during, and after antituberculosis treatmentDiagnostic Microbiology and Infectious Disease, 2009
- Accuracy of Immunodiagnostic Tests for Active Tuberculosis Using Single and Combined Results: A Multicenter TBNET-StudyPLOS ONE, 2008
- New Diagnostics for Latent and Active Tuberculosis: State of the Art and Future ProspectsSeminars in Respiratory and Critical Care Medicine, 2008
- Paediatric tuberculosisThe Lancet Infectious Diseases, 2008
- Comparison of Two Commercially Available Gamma Interferon Blood Tests for Immunodiagnosis of TuberculosisClinical and Vaccine Immunology, 2008
- Clinical application of a rapid lung-orientated immunoassay in individuals with possible tuberculosisThorax, 2008
- Rapid Diagnosis of Smear-Negative Tuberculosis Using Immunology and Microbiology with Induced Sputum in HIV-Infected and Uninfected IndividualsPLOS ONE, 2007
- Local immunodiagnosis of pulmonary tuberculosis by enzyme-linked immunospotEuropean Respiratory Journal, 2007
- Use of a T-cell interferon-γ release assay for the diagnosis of tuberculous pleurisyEuropean Respiratory Journal, 2007
- Detection of Mycobacterium tuberculosis complex with Real Time PCR: Comparison of different primer-probe sets based on the IS6110 elementJournal of Microbiological Methods, 2006